GEHC - GE HealthCare Technologies Inc Stock Analysis
GE HealthCare Technologies Inc (GEHC) is a publicly traded company listed on the NASD. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 33.85B, generates annual revenue of 20.62B, and reports net income of 2.08B. As of the latest data, the stock is trading at 74.27 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The dividend yield (0.19%) is modest, often associated with growth-oriented companies. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Hold (3.93), indicating current market sentiment. Institutional ownership is reported at 89.28%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -13.04%, trading within a 52-week range of 57.65 - 89.77.
GEHC - GE HealthCare Technologies Inc
74.27
Analyst Consensus
Hold 3.93
GEHC – Analyst Rating Summary
- Strong Buy: 8
- Buy: 11
- Hold: 8
- Sell: 1
- Strong Sell: 0
- Total Analysts: 28
| Index: | NDX, S&P 500 | P/E: | 16.31 | EPS (ttm): | 4.55 | Insider Own: | 0.29% | Shs Outstand: | 455.74M | Perf Week: | -11.87% |
| Market Cap: | 33.85B | Forward P/E: | 13.27 | EPS next Y: | 5.60 | Insider Trans: | 0.00% | Shs Float: | 454.42M | Perf Month: | -10.12% |
| Income(ttm): | 2.08B | PEG: | 1.24 | EPS next Q: | 1.05 | Inst Own: | 89.28% | Short Float: | 2.20% | Perf Quarter: | -11.15% |
| Revenue(ttm): | 20.62B | P/S: | 1.64 | EPS this Y: | 10.37% | Inst Trans: | 4.87% | Short Ratio: | 3.04 | Perf Half Y: | 0.20% |
| Book/sh: | 22.77 | P/B: | 3.26 | EPS next Y: | 10.48% | ROA: | 5.96% | Short Interest: | 10.01M | Perf Year: | -13.04% |
| Cash/sh: | 9.90 | P/C: | 7.50 | EPS next 5Y: | 10.66% | ROE: | 22.15% | 52W Range: | 57.65 - 89.77 | Perf YTD: | -9.45% |
| Dividend Est.: | 0.14 (0.19%) | P/FCF: | 22.49 | EPS past 3/5Y: | 2.53% 0.61% | ROIC: | 10.32% | 52W High: | 89.77 -17.27% | Beta: | 1.22 |
| Dividend TTM: | 0.14 (0.19%) | Quick Ratio: | 1.08 | Sales past 3/5Y: | 3.99% 3.74% | Gross Margin: | 39.70% | 52W Low: | 57.65 28.83% | Perf 5Y: | - |
| Dividend Ex-Date: | Apr 02, 2026 | Current Ratio: | 1.33 | EPS Y/Y TTM: | 4.69% | Oper. Margin: | 14.03% | RSI (14): | 30.51 | Volatility: | 3.01% 2.92% |
| Employees: | 54000 | Debt/Eq: | 1.01 | Sales Y/Y TTM: | 4.85% | Profit Margin: | 10.11% | Recom: | 1.83 | Target Price: | 93.22 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.95 | EPS Q/Q: | -17.95% | Payout: | 3.08% | Rel Volume: | 0.83 | Prev Close: | 77.11 |
| Sales Surprise: | 1.51% | EPS Surprise: | 2.97% | Sales Q/Q: | 7.13% | Earnings: | Feb 04 BMO | Avg Volume: | 3.29M | Price: | 74.27 |
| SMA20: | -8.18% | SMA50: | -9.35% | SMA200: | -3.35% | Undervalued: 25.52% | Volume: | 2,722,065 | Change: | -3.68% | |
Graham Classic formula value: 121.84
(P/E=8 * 1g) Min value: 76.24
(current P/E * 2g) Max value: 153.75
Average value: 117.28
About GE HealthCare Technologies Inc
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.